Advertisement

Index by author

April 01, 2020; Volume 373,Issue 1

A

  1. Amagase, Kikuko

    1. Leukotriene B4 Receptor Type 2 Accelerates the Healing of Intestinal Lesions by Promoting Epithelial Cell Proliferation
      Yui Matsumoto, Yukiko Matsuya, Kano Nagai, Kikuko Amagase, Kazuko Saeki, Kenjiro Matsumoto, Takehiko Yokomizo and Shinichi Kato
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 1-9; DOI: https://doi.org/10.1124/jpet.119.263145

  2. Andreassen, Kim Vietz

    1. The Dual Amylin and Calcitonin Receptor Agonist, KBP-066, Induces an Equally Potent Weight Loss Across a Broad Dose Range While Higher Doses May Further Improve Insulin Action
      Nina Sonne, Anna Thorsø Larsen, Kim Vietz Andreassen, Morten Asser Karsdal and Kim Henriksen
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 92-102; DOI: https://doi.org/10.1124/jpet.119.263723

B

  1. Banerjee, Pradeep

    1. Open Access
      Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide Receptor
      Eric Moore, Mark E. Fraley, Ian M. Bell, Christopher S. Burgey, Rebecca B. White, Chi-Chung Li, Christopher P. Regan, Andrew Danziger, Maria Stranieri Michener, Eric Hostetler, Pradeep Banerjee and Christopher Salvatore
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 160-166; DOI: https://doi.org/10.1124/jpet.119.261065

  2. Barnes, Nicholas M.

    1. Open Access
      CSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome
      Alexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. Barnes
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008

  3. Bell, Ian M.

    1. Open Access
      Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide Receptor
      Eric Moore, Mark E. Fraley, Ian M. Bell, Christopher S. Burgey, Rebecca B. White, Chi-Chung Li, Christopher P. Regan, Andrew Danziger, Maria Stranieri Michener, Eric Hostetler, Pradeep Banerjee and Christopher Salvatore
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 160-166; DOI: https://doi.org/10.1124/jpet.119.261065

  4. Borejdo, Julian

    1. Probing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic Fluorescence
      Sangram Raut, Ashwini Garud, Bhavani Nagarajan, Nirupama Sabnis, Alan Remaley, Rafal Fudala, Ignacy Gryczynski, Zygmunt Gryczynski, Sergei V. Dzyuba, Julian Borejdo and Andras Lacko
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 113-121; DOI: https://doi.org/10.1124/jpet.119.262899

  5. Brady, Catherine A.

    1. Open Access
      CSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome
      Alexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. Barnes
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008

  6. Brock, Kristian

    1. Open Access
      CSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome
      Alexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. Barnes
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008

  7. Brown, Kyle A.

    1. Dorsoventral-Specific Effects of Nerve Agent Surrogate Diisopropylfluorophosphate on Synaptic Transmission in the Mouse Hippocampus
      Kyle A. Brown, Nikolay M. Filipov and John J. Wagner
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 10-23; DOI: https://doi.org/10.1124/jpet.119.263053

  8. Burgey, Christopher S.

    1. Open Access
      Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide Receptor
      Eric Moore, Mark E. Fraley, Ian M. Bell, Christopher S. Burgey, Rebecca B. White, Chi-Chung Li, Christopher P. Regan, Andrew Danziger, Maria Stranieri Michener, Eric Hostetler, Pradeep Banerjee and Christopher Salvatore
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 160-166; DOI: https://doi.org/10.1124/jpet.119.261065

C

  1. Calo, Girolamo

    1. Detailed In Vitro Pharmacological Characterization of the Clinically Viable Nociceptin/Orphanin FQ Peptide Receptor Antagonist BTRX-246040
      Federica Ferrari, Sabrina Rizzo, Chiara Ruzza and Girolamo Calo
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 34-43; DOI: https://doi.org/10.1124/jpet.119.262865

  2. Cantoni, Orazio

    1. Arsenite-Induced Mitochondrial Superoxide Formation: Time and Concentration Requirements for the Effects of the Metalloid on the Endoplasmic Reticulum and Mitochondria
      Andrea Guidarelli, Liana Cerioni, Mara Fiorani, Alessia Catalani and Orazio Cantoni
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 62-71; DOI: https://doi.org/10.1124/jpet.119.262469

  3. Catalani, Alessia

    1. Arsenite-Induced Mitochondrial Superoxide Formation: Time and Concentration Requirements for the Effects of the Metalloid on the Endoplasmic Reticulum and Mitochondria
      Andrea Guidarelli, Liana Cerioni, Mara Fiorani, Alessia Catalani and Orazio Cantoni
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 62-71; DOI: https://doi.org/10.1124/jpet.119.262469

  4. Cerioni, Liana

    1. Arsenite-Induced Mitochondrial Superoxide Formation: Time and Concentration Requirements for the Effects of the Metalloid on the Endoplasmic Reticulum and Mitochondria
      Andrea Guidarelli, Liana Cerioni, Mara Fiorani, Alessia Catalani and Orazio Cantoni
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 62-71; DOI: https://doi.org/10.1124/jpet.119.262469

  5. Chen, Chunlin

    1. Open Access
      CSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome
      Alexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. Barnes
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008

  6. Cooper, Alison J.

    1. Open Access
      CSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome
      Alexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. Barnes
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008

D

  1. Dang, Danny

    1. Enhancing KCNQ Channel Activity Improves Neurobehavioral Recovery after Spinal Cord Injury
      Zizhen Wu, Lin Li, Fuhua Xie, Guoying Xu, Danny Dang and Qing Yang
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 72-80; DOI: https://doi.org/10.1124/jpet.119.264010

  2. Danziger, Andrew

    1. Open Access
      Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide Receptor
      Eric Moore, Mark E. Fraley, Ian M. Bell, Christopher S. Burgey, Rebecca B. White, Chi-Chung Li, Christopher P. Regan, Andrew Danziger, Maria Stranieri Michener, Eric Hostetler, Pradeep Banerjee and Christopher Salvatore
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 160-166; DOI: https://doi.org/10.1124/jpet.119.261065

  3. Demireva, Elena Y.

    1. Mice with GNAO1 R209H Movement Disorder Variant Display Hyperlocomotion Alleviated by Risperidone
      Casandra L. Larrivee, Huijie Feng, Josiah A. Quinn, Vincent S. Shaw, Jeffrey R. Leipprandt, Elena Y. Demireva, Huirong Xie and Richard R. Neubig
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 24-33; DOI: https://doi.org/10.1124/jpet.119.262733

  4. Dozono, Naoki

    1. NR2A-NMDA Receptor Blockade Reverses the Lack of Morphine Analgesia Without Affecting Chronic Pain Status in a Fibromyalgia-Like Mouse Model
      Hiroyuki Neyama, Naoki Dozono and Hiroshi Ueda
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 103-112; DOI: https://doi.org/10.1124/jpet.119.262642

  5. Dzyuba, Sergei V.

    1. Probing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic Fluorescence
      Sangram Raut, Ashwini Garud, Bhavani Nagarajan, Nirupama Sabnis, Alan Remaley, Rafal Fudala, Ignacy Gryczynski, Zygmunt Gryczynski, Sergei V. Dzyuba, Julian Borejdo and Andras Lacko
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 113-121; DOI: https://doi.org/10.1124/jpet.119.262899

F

  1. Fan, Jiaoyang

    1. Open Access
      CDDO-Me Elicits Anti–Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor Complex
      Liang Zhou, Zhongyuan Wang, Shubin Yu, Yanpeng Xiong, Jiaoyang Fan, Yansi Lyu, Zijie Su, Jiaxing Song, Shanshan Liu, Qi Sun and Desheng Lu
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 149-159; DOI: https://doi.org/10.1124/jpet.119.263434

  2. Feng, Huijie

    1. Mice with GNAO1 R209H Movement Disorder Variant Display Hyperlocomotion Alleviated by Risperidone
      Casandra L. Larrivee, Huijie Feng, Josiah A. Quinn, Vincent S. Shaw, Jeffrey R. Leipprandt, Elena Y. Demireva, Huirong Xie and Richard R. Neubig
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 24-33; DOI: https://doi.org/10.1124/jpet.119.262733

  3. Ferrari, Federica

    1. Detailed In Vitro Pharmacological Characterization of the Clinically Viable Nociceptin/Orphanin FQ Peptide Receptor Antagonist BTRX-246040
      Federica Ferrari, Sabrina Rizzo, Chiara Ruzza and Girolamo Calo
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 34-43; DOI: https://doi.org/10.1124/jpet.119.262865

  4. Filipov, Nikolay M.

    1. Dorsoventral-Specific Effects of Nerve Agent Surrogate Diisopropylfluorophosphate on Synaptic Transmission in the Mouse Hippocampus
      Kyle A. Brown, Nikolay M. Filipov and John J. Wagner
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 10-23; DOI: https://doi.org/10.1124/jpet.119.263053

  5. Fiorani, Mara

    1. Arsenite-Induced Mitochondrial Superoxide Formation: Time and Concentration Requirements for the Effects of the Metalloid on the Endoplasmic Reticulum and Mitochondria
      Andrea Guidarelli, Liana Cerioni, Mara Fiorani, Alessia Catalani and Orazio Cantoni
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 62-71; DOI: https://doi.org/10.1124/jpet.119.262469

  6. Fraley, Mark E.

    1. Open Access
      Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide Receptor
      Eric Moore, Mark E. Fraley, Ian M. Bell, Christopher S. Burgey, Rebecca B. White, Chi-Chung Li, Christopher P. Regan, Andrew Danziger, Maria Stranieri Michener, Eric Hostetler, Pradeep Banerjee and Christopher Salvatore
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 160-166; DOI: https://doi.org/10.1124/jpet.119.261065

  7. Fudala, Rafal

    1. Probing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic Fluorescence
      Sangram Raut, Ashwini Garud, Bhavani Nagarajan, Nirupama Sabnis, Alan Remaley, Rafal Fudala, Ignacy Gryczynski, Zygmunt Gryczynski, Sergei V. Dzyuba, Julian Borejdo and Andras Lacko
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 113-121; DOI: https://doi.org/10.1124/jpet.119.262899

G

  1. Garud, Ashwini

    1. Probing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic Fluorescence
      Sangram Raut, Ashwini Garud, Bhavani Nagarajan, Nirupama Sabnis, Alan Remaley, Rafal Fudala, Ignacy Gryczynski, Zygmunt Gryczynski, Sergei V. Dzyuba, Julian Borejdo and Andras Lacko
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 113-121; DOI: https://doi.org/10.1124/jpet.119.262899

  2. Gillespie, Delbert G.

    1. Open Access
      DPP4 Inhibition, NPY1-36, PYY1-36, SDF-1α, and a Hypertensive Genetic Background Conspire to Augment Cell Proliferation and Collagen Production: Effects That Are Abolished by Low Concentrations of 2-Methoxyestradiol
      Edwin K. Jackson, Delbert G. Gillespie and Stevan P. Tofovic
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 135-148; DOI: https://doi.org/10.1124/jpet.119.263467

  3. Grafton, Gillian

    1. Open Access
      CSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome
      Alexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. Barnes
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008

  4. Gryczynski, Ignacy

    1. Probing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic Fluorescence
      Sangram Raut, Ashwini Garud, Bhavani Nagarajan, Nirupama Sabnis, Alan Remaley, Rafal Fudala, Ignacy Gryczynski, Zygmunt Gryczynski, Sergei V. Dzyuba, Julian Borejdo and Andras Lacko
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 113-121; DOI: https://doi.org/10.1124/jpet.119.262899

  5. Gryczynski, Zygmunt

    1. Probing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic Fluorescence
      Sangram Raut, Ashwini Garud, Bhavani Nagarajan, Nirupama Sabnis, Alan Remaley, Rafal Fudala, Ignacy Gryczynski, Zygmunt Gryczynski, Sergei V. Dzyuba, Julian Borejdo and Andras Lacko
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 113-121; DOI: https://doi.org/10.1124/jpet.119.262899

  6. Guidarelli, Andrea

    1. Arsenite-Induced Mitochondrial Superoxide Formation: Time and Concentration Requirements for the Effects of the Metalloid on the Endoplasmic Reticulum and Mitochondria
      Andrea Guidarelli, Liana Cerioni, Mara Fiorani, Alessia Catalani and Orazio Cantoni
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 62-71; DOI: https://doi.org/10.1124/jpet.119.262469

  7. Guzzo, Peter R.

    1. Open Access
      CSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome
      Alexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. Barnes
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008

H

  1. Henriksen, Kim

    1. The Dual Amylin and Calcitonin Receptor Agonist, KBP-066, Induces an Equally Potent Weight Loss Across a Broad Dose Range While Higher Doses May Further Improve Insulin Action
      Nina Sonne, Anna Thorsø Larsen, Kim Vietz Andreassen, Morten Asser Karsdal and Kim Henriksen
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 92-102; DOI: https://doi.org/10.1124/jpet.119.263723

  2. Hostetler, Eric

    1. Open Access
      Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide Receptor
      Eric Moore, Mark E. Fraley, Ian M. Bell, Christopher S. Burgey, Rebecca B. White, Chi-Chung Li, Christopher P. Regan, Andrew Danziger, Maria Stranieri Michener, Eric Hostetler, Pradeep Banerjee and Christopher Salvatore
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 160-166; DOI: https://doi.org/10.1124/jpet.119.261065

  3. Huang, Jinkun

    1. Open Access
      CSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome
      Alexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. Barnes
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008

J

  1. Jackson, Edwin K.

    1. Open Access
      DPP4 Inhibition, NPY1-36, PYY1-36, SDF-1α, and a Hypertensive Genetic Background Conspire to Augment Cell Proliferation and Collagen Production: Effects That Are Abolished by Low Concentrations of 2-Methoxyestradiol
      Edwin K. Jackson, Delbert G. Gillespie and Stevan P. Tofovic
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 135-148; DOI: https://doi.org/10.1124/jpet.119.263467

  2. Jakimczuk, Aleksandra

    1. Open Access
      Heparin-Binding Copolymer as a Complete Antidote for Low-Molecular-Weight Heparins in Rats
      Bartlomiej Kalaska, Joanna Miklosz, Kamil Kamiński, Justyna Swieton, Aleksandra Jakimczuk, Shin-Ichi Yusa, Dariusz Pawlak, Maria Nowakowska, Krzysztof Szczubiałka and Andrzej Mogielnicki
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 51-61; DOI: https://doi.org/10.1124/jpet.119.262931

  3. Jin, Xin

    1. Oleoylethanolamide Increases Glycogen Synthesis and Inhibits Hepatic Gluconeogenesis via the LKB1/AMPK Pathway in Type 2 Diabetic Model
      Tong Ren, Ang Ma, Rengong Zhuo, Huaying Zhang, Lu Peng, Xin Jin, Enhui Yao and Lichao Yang
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 81-91; DOI: https://doi.org/10.1124/jpet.119.262675

  4. John, William S.

    1. Cannabinoid Modulation of Food-Cocaine Choice in Male Rhesus Monkeys
      William S. John, Thomas J. Martin and Michael A. Nader
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 44-50; DOI: https://doi.org/10.1124/jpet.119.263707

K

  1. Kalaska, Bartlomiej

    1. Open Access
      Heparin-Binding Copolymer as a Complete Antidote for Low-Molecular-Weight Heparins in Rats
      Bartlomiej Kalaska, Joanna Miklosz, Kamil Kamiński, Justyna Swieton, Aleksandra Jakimczuk, Shin-Ichi Yusa, Dariusz Pawlak, Maria Nowakowska, Krzysztof Szczubiałka and Andrzej Mogielnicki
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 51-61; DOI: https://doi.org/10.1124/jpet.119.262931

  2. Kamiński, Kamil

    1. Open Access
      Heparin-Binding Copolymer as a Complete Antidote for Low-Molecular-Weight Heparins in Rats
      Bartlomiej Kalaska, Joanna Miklosz, Kamil Kamiński, Justyna Swieton, Aleksandra Jakimczuk, Shin-Ichi Yusa, Dariusz Pawlak, Maria Nowakowska, Krzysztof Szczubiałka and Andrzej Mogielnicki
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 51-61; DOI: https://doi.org/10.1124/jpet.119.262931

  3. Karsdal, Morten Asser

    1. The Dual Amylin and Calcitonin Receptor Agonist, KBP-066, Induces an Equally Potent Weight Loss Across a Broad Dose Range While Higher Doses May Further Improve Insulin Action
      Nina Sonne, Anna Thorsø Larsen, Kim Vietz Andreassen, Morten Asser Karsdal and Kim Henriksen
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 92-102; DOI: https://doi.org/10.1124/jpet.119.263723

  4. Kato, Shinichi

    1. Leukotriene B4 Receptor Type 2 Accelerates the Healing of Intestinal Lesions by Promoting Epithelial Cell Proliferation
      Yui Matsumoto, Yukiko Matsuya, Kano Nagai, Kikuko Amagase, Kazuko Saeki, Kenjiro Matsumoto, Takehiko Yokomizo and Shinichi Kato
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 1-9; DOI: https://doi.org/10.1124/jpet.119.263145

L

  1. Lacko, Andras

    1. Probing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic Fluorescence
      Sangram Raut, Ashwini Garud, Bhavani Nagarajan, Nirupama Sabnis, Alan Remaley, Rafal Fudala, Ignacy Gryczynski, Zygmunt Gryczynski, Sergei V. Dzyuba, Julian Borejdo and Andras Lacko
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 113-121; DOI: https://doi.org/10.1124/jpet.119.262899

  2. Larrivee, Casandra L.

    1. Mice with GNAO1 R209H Movement Disorder Variant Display Hyperlocomotion Alleviated by Risperidone
      Casandra L. Larrivee, Huijie Feng, Josiah A. Quinn, Vincent S. Shaw, Jeffrey R. Leipprandt, Elena Y. Demireva, Huirong Xie and Richard R. Neubig
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 24-33; DOI: https://doi.org/10.1124/jpet.119.262733

  3. Larsen, Anna Thorsø

    1. The Dual Amylin and Calcitonin Receptor Agonist, KBP-066, Induces an Equally Potent Weight Loss Across a Broad Dose Range While Higher Doses May Further Improve Insulin Action
      Nina Sonne, Anna Thorsø Larsen, Kim Vietz Andreassen, Morten Asser Karsdal and Kim Henriksen
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 92-102; DOI: https://doi.org/10.1124/jpet.119.263723

  4. Leipprandt, Jeffrey R.

    1. Mice with GNAO1 R209H Movement Disorder Variant Display Hyperlocomotion Alleviated by Risperidone
      Casandra L. Larrivee, Huijie Feng, Josiah A. Quinn, Vincent S. Shaw, Jeffrey R. Leipprandt, Elena Y. Demireva, Huirong Xie and Richard R. Neubig
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 24-33; DOI: https://doi.org/10.1124/jpet.119.262733

  5. Li, Chi-Chung

    1. Open Access
      Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide Receptor
      Eric Moore, Mark E. Fraley, Ian M. Bell, Christopher S. Burgey, Rebecca B. White, Chi-Chung Li, Christopher P. Regan, Andrew Danziger, Maria Stranieri Michener, Eric Hostetler, Pradeep Banerjee and Christopher Salvatore
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 160-166; DOI: https://doi.org/10.1124/jpet.119.261065

  6. Li, Lin

    1. Enhancing KCNQ Channel Activity Improves Neurobehavioral Recovery after Spinal Cord Injury
      Zizhen Wu, Lin Li, Fuhua Xie, Guoying Xu, Danny Dang and Qing Yang
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 72-80; DOI: https://doi.org/10.1124/jpet.119.264010

  7. Liu, Shanshan

    1. Open Access
      CDDO-Me Elicits Anti–Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor Complex
      Liang Zhou, Zhongyuan Wang, Shubin Yu, Yanpeng Xiong, Jiaoyang Fan, Yansi Lyu, Zijie Su, Jiaxing Song, Shanshan Liu, Qi Sun and Desheng Lu
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 149-159; DOI: https://doi.org/10.1124/jpet.119.263434

  8. Liu, Shuang

    1. Open Access
      CSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome
      Alexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. Barnes
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008

  9. Lu, Desheng

    1. Open Access
      CDDO-Me Elicits Anti–Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor Complex
      Liang Zhou, Zhongyuan Wang, Shubin Yu, Yanpeng Xiong, Jiaoyang Fan, Yansi Lyu, Zijie Su, Jiaxing Song, Shanshan Liu, Qi Sun and Desheng Lu
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 149-159; DOI: https://doi.org/10.1124/jpet.119.263434

  10. Lyu, Yansi

    1. Open Access
      CDDO-Me Elicits Anti–Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor Complex
      Liang Zhou, Zhongyuan Wang, Shubin Yu, Yanpeng Xiong, Jiaoyang Fan, Yansi Lyu, Zijie Su, Jiaxing Song, Shanshan Liu, Qi Sun and Desheng Lu
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 149-159; DOI: https://doi.org/10.1124/jpet.119.263434

M

  1. Ma, Ang

    1. Oleoylethanolamide Increases Glycogen Synthesis and Inhibits Hepatic Gluconeogenesis via the LKB1/AMPK Pathway in Type 2 Diabetic Model
      Tong Ren, Ang Ma, Rengong Zhuo, Huaying Zhang, Lu Peng, Xin Jin, Enhui Yao and Lichao Yang
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 81-91; DOI: https://doi.org/10.1124/jpet.119.262675

  2. Manning, David D.

    1. Open Access
      CSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome
      Alexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. Barnes
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008

  3. Martin, Thomas J.

    1. Cannabinoid Modulation of Food-Cocaine Choice in Male Rhesus Monkeys
      William S. John, Thomas J. Martin and Michael A. Nader
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 44-50; DOI: https://doi.org/10.1124/jpet.119.263707

  4. Matsumoto, Kenjiro

    1. Leukotriene B4 Receptor Type 2 Accelerates the Healing of Intestinal Lesions by Promoting Epithelial Cell Proliferation
      Yui Matsumoto, Yukiko Matsuya, Kano Nagai, Kikuko Amagase, Kazuko Saeki, Kenjiro Matsumoto, Takehiko Yokomizo and Shinichi Kato
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 1-9; DOI: https://doi.org/10.1124/jpet.119.263145

  5. Matsumoto, Yui

    1. Leukotriene B4 Receptor Type 2 Accelerates the Healing of Intestinal Lesions by Promoting Epithelial Cell Proliferation
      Yui Matsumoto, Yukiko Matsuya, Kano Nagai, Kikuko Amagase, Kazuko Saeki, Kenjiro Matsumoto, Takehiko Yokomizo and Shinichi Kato
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 1-9; DOI: https://doi.org/10.1124/jpet.119.263145

  6. Matsuya, Yukiko

    1. Leukotriene B4 Receptor Type 2 Accelerates the Healing of Intestinal Lesions by Promoting Epithelial Cell Proliferation
      Yui Matsumoto, Yukiko Matsuya, Kano Nagai, Kikuko Amagase, Kazuko Saeki, Kenjiro Matsumoto, Takehiko Yokomizo and Shinichi Kato
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 1-9; DOI: https://doi.org/10.1124/jpet.119.263145

  7. Michener, Maria Stranieri

    1. Open Access
      Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide Receptor
      Eric Moore, Mark E. Fraley, Ian M. Bell, Christopher S. Burgey, Rebecca B. White, Chi-Chung Li, Christopher P. Regan, Andrew Danziger, Maria Stranieri Michener, Eric Hostetler, Pradeep Banerjee and Christopher Salvatore
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 160-166; DOI: https://doi.org/10.1124/jpet.119.261065

  8. Miklosz, Joanna

    1. Open Access
      Heparin-Binding Copolymer as a Complete Antidote for Low-Molecular-Weight Heparins in Rats
      Bartlomiej Kalaska, Joanna Miklosz, Kamil Kamiński, Justyna Swieton, Aleksandra Jakimczuk, Shin-Ichi Yusa, Dariusz Pawlak, Maria Nowakowska, Krzysztof Szczubiałka and Andrzej Mogielnicki
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 51-61; DOI: https://doi.org/10.1124/jpet.119.262931

  9. Mogielnicki, Andrzej

    1. Open Access
      Heparin-Binding Copolymer as a Complete Antidote for Low-Molecular-Weight Heparins in Rats
      Bartlomiej Kalaska, Joanna Miklosz, Kamil Kamiński, Justyna Swieton, Aleksandra Jakimczuk, Shin-Ichi Yusa, Dariusz Pawlak, Maria Nowakowska, Krzysztof Szczubiałka and Andrzej Mogielnicki
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 51-61; DOI: https://doi.org/10.1124/jpet.119.262931

  10. Moore, Eric

    1. Open Access
      Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide Receptor
      Eric Moore, Mark E. Fraley, Ian M. Bell, Christopher S. Burgey, Rebecca B. White, Chi-Chung Li, Christopher P. Regan, Andrew Danziger, Maria Stranieri Michener, Eric Hostetler, Pradeep Banerjee and Christopher Salvatore
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 160-166; DOI: https://doi.org/10.1124/jpet.119.261065

  11. Moore, Nicholas A.

    1. Open Access
      CSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome
      Alexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. Barnes
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008

N

  1. Nader, Michael A.

    1. Cannabinoid Modulation of Food-Cocaine Choice in Male Rhesus Monkeys
      William S. John, Thomas J. Martin and Michael A. Nader
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 44-50; DOI: https://doi.org/10.1124/jpet.119.263707

  2. Nagai, Kano

    1. Leukotriene B4 Receptor Type 2 Accelerates the Healing of Intestinal Lesions by Promoting Epithelial Cell Proliferation
      Yui Matsumoto, Yukiko Matsuya, Kano Nagai, Kikuko Amagase, Kazuko Saeki, Kenjiro Matsumoto, Takehiko Yokomizo and Shinichi Kato
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 1-9; DOI: https://doi.org/10.1124/jpet.119.263145

  3. Nagarajan, Bhavani

    1. Probing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic Fluorescence
      Sangram Raut, Ashwini Garud, Bhavani Nagarajan, Nirupama Sabnis, Alan Remaley, Rafal Fudala, Ignacy Gryczynski, Zygmunt Gryczynski, Sergei V. Dzyuba, Julian Borejdo and Andras Lacko
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 113-121; DOI: https://doi.org/10.1124/jpet.119.262899

  4. Neubig, Richard R.

    1. Mice with GNAO1 R209H Movement Disorder Variant Display Hyperlocomotion Alleviated by Risperidone
      Casandra L. Larrivee, Huijie Feng, Josiah A. Quinn, Vincent S. Shaw, Jeffrey R. Leipprandt, Elena Y. Demireva, Huirong Xie and Richard R. Neubig
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 24-33; DOI: https://doi.org/10.1124/jpet.119.262733

  5. Neyama, Hiroyuki

    1. NR2A-NMDA Receptor Blockade Reverses the Lack of Morphine Analgesia Without Affecting Chronic Pain Status in a Fibromyalgia-Like Mouse Model
      Hiroyuki Neyama, Naoki Dozono and Hiroshi Ueda
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 103-112; DOI: https://doi.org/10.1124/jpet.119.262642

  6. Nowakowska, Maria

    1. Open Access
      Heparin-Binding Copolymer as a Complete Antidote for Low-Molecular-Weight Heparins in Rats
      Bartlomiej Kalaska, Joanna Miklosz, Kamil Kamiński, Justyna Swieton, Aleksandra Jakimczuk, Shin-Ichi Yusa, Dariusz Pawlak, Maria Nowakowska, Krzysztof Szczubiałka and Andrzej Mogielnicki
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 51-61; DOI: https://doi.org/10.1124/jpet.119.262931

P

  1. Pawlak, Dariusz

    1. Open Access
      Heparin-Binding Copolymer as a Complete Antidote for Low-Molecular-Weight Heparins in Rats
      Bartlomiej Kalaska, Joanna Miklosz, Kamil Kamiński, Justyna Swieton, Aleksandra Jakimczuk, Shin-Ichi Yusa, Dariusz Pawlak, Maria Nowakowska, Krzysztof Szczubiałka and Andrzej Mogielnicki
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 51-61; DOI: https://doi.org/10.1124/jpet.119.262931

  2. Peng, Lu

    1. Oleoylethanolamide Increases Glycogen Synthesis and Inhibits Hepatic Gluconeogenesis via the LKB1/AMPK Pathway in Type 2 Diabetic Model
      Tong Ren, Ang Ma, Rengong Zhuo, Huaying Zhang, Lu Peng, Xin Jin, Enhui Yao and Lichao Yang
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 81-91; DOI: https://doi.org/10.1124/jpet.119.262675

  3. Powell, Andrew D.

    1. Open Access
      CSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome
      Alexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. Barnes
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008

Q

  1. Quinn, Josiah A.

    1. Mice with GNAO1 R209H Movement Disorder Variant Display Hyperlocomotion Alleviated by Risperidone
      Casandra L. Larrivee, Huijie Feng, Josiah A. Quinn, Vincent S. Shaw, Jeffrey R. Leipprandt, Elena Y. Demireva, Huirong Xie and Richard R. Neubig
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 24-33; DOI: https://doi.org/10.1124/jpet.119.262733

  2. Qureshi, Omar

    1. Open Access
      CSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome
      Alexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. Barnes
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008

R

  1. Raut, Sangram

    1. Probing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic Fluorescence
      Sangram Raut, Ashwini Garud, Bhavani Nagarajan, Nirupama Sabnis, Alan Remaley, Rafal Fudala, Ignacy Gryczynski, Zygmunt Gryczynski, Sergei V. Dzyuba, Julian Borejdo and Andras Lacko
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 113-121; DOI: https://doi.org/10.1124/jpet.119.262899

  2. Regan, Christopher P.

    1. Open Access
      Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide Receptor
      Eric Moore, Mark E. Fraley, Ian M. Bell, Christopher S. Burgey, Rebecca B. White, Chi-Chung Li, Christopher P. Regan, Andrew Danziger, Maria Stranieri Michener, Eric Hostetler, Pradeep Banerjee and Christopher Salvatore
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 160-166; DOI: https://doi.org/10.1124/jpet.119.261065

  3. Remaley, Alan

    1. Probing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic Fluorescence
      Sangram Raut, Ashwini Garud, Bhavani Nagarajan, Nirupama Sabnis, Alan Remaley, Rafal Fudala, Ignacy Gryczynski, Zygmunt Gryczynski, Sergei V. Dzyuba, Julian Borejdo and Andras Lacko
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 113-121; DOI: https://doi.org/10.1124/jpet.119.262899

  4. Ren, Tong

    1. Oleoylethanolamide Increases Glycogen Synthesis and Inhibits Hepatic Gluconeogenesis via the LKB1/AMPK Pathway in Type 2 Diabetic Model
      Tong Ren, Ang Ma, Rengong Zhuo, Huaying Zhang, Lu Peng, Xin Jin, Enhui Yao and Lichao Yang
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 81-91; DOI: https://doi.org/10.1124/jpet.119.262675

  5. Rizzo, Sabrina

    1. Detailed In Vitro Pharmacological Characterization of the Clinically Viable Nociceptin/Orphanin FQ Peptide Receptor Antagonist BTRX-246040
      Federica Ferrari, Sabrina Rizzo, Chiara Ruzza and Girolamo Calo
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 34-43; DOI: https://doi.org/10.1124/jpet.119.262865

  6. Roberts, Alexander

    1. Open Access
      CSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome
      Alexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. Barnes
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008

  7. Ruzza, Chiara

    1. Detailed In Vitro Pharmacological Characterization of the Clinically Viable Nociceptin/Orphanin FQ Peptide Receptor Antagonist BTRX-246040
      Federica Ferrari, Sabrina Rizzo, Chiara Ruzza and Girolamo Calo
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 34-43; DOI: https://doi.org/10.1124/jpet.119.262865

S

  1. Sabnis, Nirupama

    1. Probing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic Fluorescence
      Sangram Raut, Ashwini Garud, Bhavani Nagarajan, Nirupama Sabnis, Alan Remaley, Rafal Fudala, Ignacy Gryczynski, Zygmunt Gryczynski, Sergei V. Dzyuba, Julian Borejdo and Andras Lacko
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 113-121; DOI: https://doi.org/10.1124/jpet.119.262899

  2. Saeki, Kazuko

    1. Leukotriene B4 Receptor Type 2 Accelerates the Healing of Intestinal Lesions by Promoting Epithelial Cell Proliferation
      Yui Matsumoto, Yukiko Matsuya, Kano Nagai, Kikuko Amagase, Kazuko Saeki, Kenjiro Matsumoto, Takehiko Yokomizo and Shinichi Kato
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 1-9; DOI: https://doi.org/10.1124/jpet.119.263145

  3. Salvatore, Christopher

    1. Open Access
      Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide Receptor
      Eric Moore, Mark E. Fraley, Ian M. Bell, Christopher S. Burgey, Rebecca B. White, Chi-Chung Li, Christopher P. Regan, Andrew Danziger, Maria Stranieri Michener, Eric Hostetler, Pradeep Banerjee and Christopher Salvatore
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 160-166; DOI: https://doi.org/10.1124/jpet.119.261065

  4. Sargent, Bruce J.

    1. Open Access
      CSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome
      Alexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. Barnes
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008

  5. Shaw, Vincent S.

    1. Mice with GNAO1 R209H Movement Disorder Variant Display Hyperlocomotion Alleviated by Risperidone
      Casandra L. Larrivee, Huijie Feng, Josiah A. Quinn, Vincent S. Shaw, Jeffrey R. Leipprandt, Elena Y. Demireva, Huirong Xie and Richard R. Neubig
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 24-33; DOI: https://doi.org/10.1124/jpet.119.262733

  6. Song, Jiaxing

    1. Open Access
      CDDO-Me Elicits Anti–Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor Complex
      Liang Zhou, Zhongyuan Wang, Shubin Yu, Yanpeng Xiong, Jiaoyang Fan, Yansi Lyu, Zijie Su, Jiaxing Song, Shanshan Liu, Qi Sun and Desheng Lu
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 149-159; DOI: https://doi.org/10.1124/jpet.119.263434

  7. Sonne, Nina

    1. The Dual Amylin and Calcitonin Receptor Agonist, KBP-066, Induces an Equally Potent Weight Loss Across a Broad Dose Range While Higher Doses May Further Improve Insulin Action
      Nina Sonne, Anna Thorsø Larsen, Kim Vietz Andreassen, Morten Asser Karsdal and Kim Henriksen
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 92-102; DOI: https://doi.org/10.1124/jpet.119.263723

  8. Stamataki, Zania

    1. Open Access
      CSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome
      Alexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. Barnes
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008

  9. Su, Zijie

    1. Open Access
      CDDO-Me Elicits Anti–Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor Complex
      Liang Zhou, Zhongyuan Wang, Shubin Yu, Yanpeng Xiong, Jiaoyang Fan, Yansi Lyu, Zijie Su, Jiaxing Song, Shanshan Liu, Qi Sun and Desheng Lu
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 149-159; DOI: https://doi.org/10.1124/jpet.119.263434

  10. Sun, Qi

    1. Open Access
      CDDO-Me Elicits Anti–Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor Complex
      Liang Zhou, Zhongyuan Wang, Shubin Yu, Yanpeng Xiong, Jiaoyang Fan, Yansi Lyu, Zijie Su, Jiaxing Song, Shanshan Liu, Qi Sun and Desheng Lu
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 149-159; DOI: https://doi.org/10.1124/jpet.119.263434

  11. Swieton, Justyna

    1. Open Access
      Heparin-Binding Copolymer as a Complete Antidote for Low-Molecular-Weight Heparins in Rats
      Bartlomiej Kalaska, Joanna Miklosz, Kamil Kamiński, Justyna Swieton, Aleksandra Jakimczuk, Shin-Ichi Yusa, Dariusz Pawlak, Maria Nowakowska, Krzysztof Szczubiałka and Andrzej Mogielnicki
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 51-61; DOI: https://doi.org/10.1124/jpet.119.262931

  12. Szczubiałka, Krzysztof

    1. Open Access
      Heparin-Binding Copolymer as a Complete Antidote for Low-Molecular-Weight Heparins in Rats
      Bartlomiej Kalaska, Joanna Miklosz, Kamil Kamiński, Justyna Swieton, Aleksandra Jakimczuk, Shin-Ichi Yusa, Dariusz Pawlak, Maria Nowakowska, Krzysztof Szczubiałka and Andrzej Mogielnicki
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 51-61; DOI: https://doi.org/10.1124/jpet.119.262931

T

  1. Tofovic, Stevan P.

    1. Open Access
      DPP4 Inhibition, NPY1-36, PYY1-36, SDF-1α, and a Hypertensive Genetic Background Conspire to Augment Cell Proliferation and Collagen Production: Effects That Are Abolished by Low Concentrations of 2-Methoxyestradiol
      Edwin K. Jackson, Delbert G. Gillespie and Stevan P. Tofovic
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 135-148; DOI: https://doi.org/10.1124/jpet.119.263467

U

  1. Ueda, Hiroshi

    1. NR2A-NMDA Receptor Blockade Reverses the Lack of Morphine Analgesia Without Affecting Chronic Pain Status in a Fibromyalgia-Like Mouse Model
      Hiroyuki Neyama, Naoki Dozono and Hiroshi Ueda
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 103-112; DOI: https://doi.org/10.1124/jpet.119.262642

W

  1. Wagner, John J.

    1. Dorsoventral-Specific Effects of Nerve Agent Surrogate Diisopropylfluorophosphate on Synaptic Transmission in the Mouse Hippocampus
      Kyle A. Brown, Nikolay M. Filipov and John J. Wagner
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 10-23; DOI: https://doi.org/10.1124/jpet.119.263053

  2. Wang, Zhongyuan

    1. Open Access
      CDDO-Me Elicits Anti–Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor Complex
      Liang Zhou, Zhongyuan Wang, Shubin Yu, Yanpeng Xiong, Jiaoyang Fan, Yansi Lyu, Zijie Su, Jiaxing Song, Shanshan Liu, Qi Sun and Desheng Lu
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 149-159; DOI: https://doi.org/10.1124/jpet.119.263434

  3. White, Rebecca B.

    1. Open Access
      Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide Receptor
      Eric Moore, Mark E. Fraley, Ian M. Bell, Christopher S. Burgey, Rebecca B. White, Chi-Chung Li, Christopher P. Regan, Andrew Danziger, Maria Stranieri Michener, Eric Hostetler, Pradeep Banerjee and Christopher Salvatore
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 160-166; DOI: https://doi.org/10.1124/jpet.119.261065

  4. Wu, Zizhen

    1. Enhancing KCNQ Channel Activity Improves Neurobehavioral Recovery after Spinal Cord Injury
      Zizhen Wu, Lin Li, Fuhua Xie, Guoying Xu, Danny Dang and Qing Yang
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 72-80; DOI: https://doi.org/10.1124/jpet.119.264010

X

  1. Xie, Dejian

    1. Open Access
      CSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome
      Alexander Roberts, Gillian Grafton, Andrew D. Powell, Kristian Brock, Chunlin Chen, Dejian Xie, Jinkun Huang, Shuang Liu, Alison J. Cooper, Catherine A. Brady, Omar Qureshi, Zania Stamataki, David D. Manning, Nicholas A. Moore, Bruce J. Sargent, Peter R. Guzzo and Nicholas M. Barnes
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 122-134; DOI: https://doi.org/10.1124/jpet.119.261008

  2. Xie, Fuhua

    1. Enhancing KCNQ Channel Activity Improves Neurobehavioral Recovery after Spinal Cord Injury
      Zizhen Wu, Lin Li, Fuhua Xie, Guoying Xu, Danny Dang and Qing Yang
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 72-80; DOI: https://doi.org/10.1124/jpet.119.264010

  3. Xie, Huirong

    1. Mice with GNAO1 R209H Movement Disorder Variant Display Hyperlocomotion Alleviated by Risperidone
      Casandra L. Larrivee, Huijie Feng, Josiah A. Quinn, Vincent S. Shaw, Jeffrey R. Leipprandt, Elena Y. Demireva, Huirong Xie and Richard R. Neubig
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 24-33; DOI: https://doi.org/10.1124/jpet.119.262733

  4. Xiong, Yanpeng

    1. Open Access
      CDDO-Me Elicits Anti–Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor Complex
      Liang Zhou, Zhongyuan Wang, Shubin Yu, Yanpeng Xiong, Jiaoyang Fan, Yansi Lyu, Zijie Su, Jiaxing Song, Shanshan Liu, Qi Sun and Desheng Lu
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 149-159; DOI: https://doi.org/10.1124/jpet.119.263434

  5. Xu, Guoying

    1. Enhancing KCNQ Channel Activity Improves Neurobehavioral Recovery after Spinal Cord Injury
      Zizhen Wu, Lin Li, Fuhua Xie, Guoying Xu, Danny Dang and Qing Yang
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 72-80; DOI: https://doi.org/10.1124/jpet.119.264010

Y

  1. Yang, Lichao

    1. Oleoylethanolamide Increases Glycogen Synthesis and Inhibits Hepatic Gluconeogenesis via the LKB1/AMPK Pathway in Type 2 Diabetic Model
      Tong Ren, Ang Ma, Rengong Zhuo, Huaying Zhang, Lu Peng, Xin Jin, Enhui Yao and Lichao Yang
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 81-91; DOI: https://doi.org/10.1124/jpet.119.262675

  2. Yang, Qing

    1. Enhancing KCNQ Channel Activity Improves Neurobehavioral Recovery after Spinal Cord Injury
      Zizhen Wu, Lin Li, Fuhua Xie, Guoying Xu, Danny Dang and Qing Yang
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 72-80; DOI: https://doi.org/10.1124/jpet.119.264010

  3. Yao, Enhui

    1. Oleoylethanolamide Increases Glycogen Synthesis and Inhibits Hepatic Gluconeogenesis via the LKB1/AMPK Pathway in Type 2 Diabetic Model
      Tong Ren, Ang Ma, Rengong Zhuo, Huaying Zhang, Lu Peng, Xin Jin, Enhui Yao and Lichao Yang
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 81-91; DOI: https://doi.org/10.1124/jpet.119.262675

  4. Yokomizo, Takehiko

    1. Leukotriene B4 Receptor Type 2 Accelerates the Healing of Intestinal Lesions by Promoting Epithelial Cell Proliferation
      Yui Matsumoto, Yukiko Matsuya, Kano Nagai, Kikuko Amagase, Kazuko Saeki, Kenjiro Matsumoto, Takehiko Yokomizo and Shinichi Kato
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 1-9; DOI: https://doi.org/10.1124/jpet.119.263145

  5. Yu, Shubin

    1. Open Access
      CDDO-Me Elicits Anti–Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor Complex
      Liang Zhou, Zhongyuan Wang, Shubin Yu, Yanpeng Xiong, Jiaoyang Fan, Yansi Lyu, Zijie Su, Jiaxing Song, Shanshan Liu, Qi Sun and Desheng Lu
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 149-159; DOI: https://doi.org/10.1124/jpet.119.263434

  6. Yusa, Shin-Ichi

    1. Open Access
      Heparin-Binding Copolymer as a Complete Antidote for Low-Molecular-Weight Heparins in Rats
      Bartlomiej Kalaska, Joanna Miklosz, Kamil Kamiński, Justyna Swieton, Aleksandra Jakimczuk, Shin-Ichi Yusa, Dariusz Pawlak, Maria Nowakowska, Krzysztof Szczubiałka and Andrzej Mogielnicki
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 51-61; DOI: https://doi.org/10.1124/jpet.119.262931

Z

  1. Zhang, Huaying

    1. Oleoylethanolamide Increases Glycogen Synthesis and Inhibits Hepatic Gluconeogenesis via the LKB1/AMPK Pathway in Type 2 Diabetic Model
      Tong Ren, Ang Ma, Rengong Zhuo, Huaying Zhang, Lu Peng, Xin Jin, Enhui Yao and Lichao Yang
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 81-91; DOI: https://doi.org/10.1124/jpet.119.262675

  2. Zhou, Liang

    1. Open Access
      CDDO-Me Elicits Anti–Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor Complex
      Liang Zhou, Zhongyuan Wang, Shubin Yu, Yanpeng Xiong, Jiaoyang Fan, Yansi Lyu, Zijie Su, Jiaxing Song, Shanshan Liu, Qi Sun and Desheng Lu
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 149-159; DOI: https://doi.org/10.1124/jpet.119.263434

  3. Zhuo, Rengong

    1. Oleoylethanolamide Increases Glycogen Synthesis and Inhibits Hepatic Gluconeogenesis via the LKB1/AMPK Pathway in Type 2 Diabetic Model
      Tong Ren, Ang Ma, Rengong Zhuo, Huaying Zhang, Lu Peng, Xin Jin, Enhui Yao and Lichao Yang
      Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 81-91; DOI: https://doi.org/10.1124/jpet.119.262675
Back to top

In this issue